Evaluation of a Thin Strut Metallic Stent: the Elixir DynamX Clinical Study
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Percutaneous Coronary Intervention
- First Posted Date
- 2018-02-12
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Elixir Medical Corporation
- Target Recruit Count
- 50
- Registration Number
- NCT03429894
- Locations
- 🇧🇪
AZ Middelheim Hospital, Antwerp, Belgium
🇮🇹Ospendale San Raffaele, Milan, Italy
The DESappear Study: Drug Eluting Scaffold
- Conditions
- Peripheral Vascular Disease
- Interventions
- Device: Akesys Prava Scaffold
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2021-06-01
- Lead Sponsor
- Elixir Medical Corporation
- Target Recruit Count
- 21
- Registration Number
- NCT02869087
- Locations
- 🇦🇹
LKH University Hospital Graz, Graz, Steiermark, Austria
🇧🇪AZ Sint Blasius, Dendermonde, Dendermonde, Brussels, Belgium
🇩🇪Bonifatius Hospital, Lingen, Niedersachsen, Germany
DESolve® X-Pand Global Post Market Registry
- Conditions
- Coronary Artery Stenosis
- Interventions
- Device: PTCA - Desolve Scaffold
- First Posted Date
- 2015-05-25
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Elixir Medical Corporation
- Target Recruit Count
- 154
- Registration Number
- NCT02453035
- Locations
- 🇩🇪
Krankenhaus der Barmherzigen Brüder, Trier, Germany
🇳🇱St. Antonius Ziekenhuis, Nieuwegein, Netherlands
🇩🇪Universitätsklinikum Giessen, Giessen, Germany
Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial
- Conditions
- Coronary Artery Disease
- Interventions
- Device: DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Elixir Medical Corporation
- Target Recruit Count
- 126
- Registration Number
- NCT02086045
- Locations
- 🇧🇷
Instituto Dante Pazzanese, Sao Paulo, Brazil
🇩🇰Aarhus University Hospital, Skejby, Aarhus N, Denmark
🇧🇪AZ Middelheim Hospital, Antwerp, Belgium
Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial
- Conditions
- Coronary Artery Disease
- Interventions
- Device: DESolve Novolimus Eluting Bioresorbable Coronary Scaffold
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Elixir Medical Corporation
- Target Recruit Count
- 16
- Registration Number
- NCT02086006
- Locations
- 🇳🇿
Auckland City Hospital, Auckland, New Zealand
🇳🇿Mercy Angiography Unit, Auckland, New Zealand
🇧🇪AZ Middelheim Hospital, Antwerp, Belgium
DESolve Post-Approval Study
- Conditions
- Coronary Artery Disease
- Interventions
- Device: coronary intervention
- First Posted Date
- 2013-12-17
- Last Posted Date
- 2020-04-08
- Lead Sponsor
- Elixir Medical Corporation
- Target Recruit Count
- 102
- Registration Number
- NCT02013349
- Locations
- 🇯🇴
Jordan Hospital, Amman, Jordan
🇯🇴King Abdullah University Hospital, Irbid, Jordan
🇩🇪Universitätsklinikum Giessen und Marburg GmbH, Giessen, Germany
EXCELLA Post-Approval Study
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Subjects receiving DESyne Novolimus Eluting CSS
- First Posted Date
- 2013-12-12
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Elixir Medical Corporation
- Target Recruit Count
- 57
- Registration Number
- NCT02009956
- Locations
- 🇯🇴
Jordan Hospital, Amman, Jordan
🇯🇴King Abdullah University Hospital, Irbid, Jordan
🇩🇪Krankenhaus der Barmherzigen Brüder, Trier, Germany
Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"
- Conditions
- Coronary Artery Disease
- Interventions
- Device: DESyne BD Novolimus Stent SystemDevice: DESyne Novolimus Stent SystemDevice: Medtronic Endeavor Coronary Stent System
- First Posted Date
- 2008-11-18
- Last Posted Date
- 2020-04-08
- Lead Sponsor
- Elixir Medical Corporation
- Target Recruit Count
- 360
- Registration Number
- NCT00792753
- Locations
- 🇳🇿
Auckland City Hospital, Auckland, New Zealand
🇩🇪Universitäres Herz- und Gefäßzentrum, Hamburg, Germany
🇦🇺Monash Medical Center, Melbourne, Australia